A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma

Por Shaw, D M, Connolly, N B, Patel, P M, Kilany, S, Hedlund, G, Nordle, Ö, Forsberg, G, Zweit, J, Stern, P L, Hawkins, R E
Publicado em 2007

Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases

Por Burke, D, Davies, M M, Zweit, J, Flower, M A, Ott, R J, Dworkin, M J, Glover, C, McCready, V R, Carnochan, P, Allen-Mersh, T G
Publicado em 2001